Global Pharmaceutical Contract Research And Manufacturing Market 2026-2030

Description

The global pharmaceutical contract research and manufacturing market is forecasted to grow by USD 190387.9 mn during 2025-2030, accelerating at a CAGR of 11.9% during the forecast period. The report on the global pharmaceutical contract research and manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerated adoption of digital technologies, rise of personalized medicine initiatives, expansion of rare disease therapeutics .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	10.6%
CAGR	11.9%
Incremental Value	$190387.9 mn

Technavio's global pharmaceutical contract research and manufacturing market is segmented as below:

By Service

By End-User

Big pharmaceuticals
SMS pharmaceuticals
Generic pharmaceuticals

By Product Type

Small molecules
Large molecules

Geography

Asia
North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
Rest of World (ROW)
Rest of World (ROW)

This study identifies the expansion of cell therapies as one of the prime reasons driving the global pharmaceutical contract research and manufacturing market growth during the next few years. Also, adoption of green chemistry and sustainability and proliferation of decentralized clinical trial frameworks will lead to sizable demand in the market.

The report on the global pharmaceutical contract research and manufacturing market covers the following areas:

Global pharmaceutical contract research and manufacturing market sizing
Global pharmaceutical contract research and manufacturing market forecast
Global pharmaceutical contract research and manufacturing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global pharmaceutical contract research and manufacturing market vendors that include Almac Group Ltd., Boehringer Ingelheim GmbH, Cambrex Corp., Catalent Inc., Charles River Laboratories, Corden Pharma Intl. GmbH, Curia Global Inc., Divis Laboratories Ltd., Eurofins Scientific SE, Evonik Industries AG, FUJIFILM Holdings Corp., Hovione S.A., ICON plc, IQVIA Holdings Inc., Laboratory Holdings Inc., Lonza Group Ltd., Parexel International Corp., Piramal Pharma Solutions, Recipharm AB, Samsung Biologics Co. Ltd., Siegfried Holding AG, Syngene International Ltd., Thermo Fisher Scientific Inc., Vetter Pharma Fertigung GmbH, WuXi AppTec Co. Ltd.. Also, the global pharmaceutical contract research and manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR41601

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Service
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Pharmaceutical Contract Research And Manufacturing Market 2020 - 2024
- Historic Market Size - Data Table on Global Pharmaceutical Contract Research And Manufacturing Market 2020 - 2024 ($ million)
5.2 Service segment analysis 2020 - 2024
- Historic Market Size - Service Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Pharmaceutical Contract Research and Manufacturing Market
6.2 Impact of geopolitical conflicts on Global Pharmaceutical Contract Research and Manufacturing Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Service

8.1 Market segments
8.2 Comparison by Service
8.3 CMO - Market size and forecast 2025-2030
8.4 CRO - Market size and forecast 2025-2030
8.5 Market opportunity by Service
- Market opportunity by Service ($ million)

9 Market Segmentation by End-user

9.1 Market segments
9.2 Comparison by End-user
9.3 Big pharmaceuticals - Market size and forecast 2025-2030
9.4 SMS pharmaceuticals - Market size and forecast 2025-2030
9.5 Generic pharmaceuticals - Market size and forecast 2025-2030
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)

10 Market Segmentation by Product Type

10.1 Market segments
10.2 Comparison by Product Type
10.3 Small molecules - Market size and forecast 2025-2030
10.4 Large molecules - Market size and forecast 2025-2030
10.5 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 Asia - Market size and forecast 2025-2030
- 12.3.1 China - Market size and forecast 2025-2030
- 12.3.2 India - Market size and forecast 2025-2030
- 12.3.3 Japan - Market size and forecast 2025-2030
- 12.3.4 South Korea - Market size and forecast 2025-2030
- 12.3.5 Thailand - Market size and forecast 2025-2030
- 12.3.6 Indonesia - Market size and forecast 2025-2030
12.4 North America - Market size and forecast 2025-2030
- 12.4.1 US - Market size and forecast 2025-2030
- 12.4.2 Canada - Market size and forecast 2025-2030
- 12.4.3 Mexico - Market size and forecast 2025-2030
12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 UK - Market size and forecast 2025-2030
- 12.5.3 France - Market size and forecast 2025-2030
- 12.5.4 Italy - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 The Netherlands - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Israel - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.6.7 Argentina - Market size and forecast 2025-2030
- 12.6.8 Colombia - Market size and forecast 2025-2030
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Accelerated adoption of digital technologies
- Rise of personalized medicine initiatives
- Expansion of rare disease therapeutics
13.2 Market challenges
- Geopolitical supply chain vulnerabilities impacting markets
- Escalating regulatory compliance and oversight
- Technological complexity and workforce constraints
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Expansion of cell therapies
- Adoption of green chemistry and sustainability
- Proliferation of decentralized clinical trial frameworks

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Charles River Laboratories
- Charles River Laboratories - Overview
- Charles River Laboratories - Business segments
- Charles River Laboratories - Key offerings
- Charles River Laboratories - Segment focus
- SWOT
15.5 Divis Laboratories Ltd.
- Divis Laboratories Ltd. - Overview
- Divis Laboratories Ltd. - Product / Service
- Divis Laboratories Ltd. - Key offerings
- SWOT
15.6 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
15.7 Evonik Industries AG
- Evonik Industries AG - Overview
- Evonik Industries AG - Business segments
- Evonik Industries AG - Key news
- Evonik Industries AG - Key offerings
- Evonik Industries AG - Segment focus
- SWOT
15.8 FUJIFILM Holdings Corp.
- FUJIFILM Holdings Corp. - Overview
- FUJIFILM Holdings Corp. - Business segments
- FUJIFILM Holdings Corp. - Key news
- FUJIFILM Holdings Corp. - Key offerings
- FUJIFILM Holdings Corp. - Segment focus
- SWOT
15.9 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
15.10 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
15.11 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
15.12 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
15.13 Piramal Pharma Solutions
- Piramal Pharma Solutions - Overview
- Piramal Pharma Solutions - Business segments
- Piramal Pharma Solutions - Key offerings
- Piramal Pharma Solutions - Segment focus
- SWOT
15.14 Samsung Biologics Co. Ltd.
- Samsung Biologics Co. Ltd. - Overview
- Samsung Biologics Co. Ltd. - Product / Service
- Samsung Biologics Co. Ltd. - Key offerings
- SWOT
15.15 Siegfried Holding AG
- Siegfried Holding AG - Overview
- Siegfried Holding AG - Business segments
- Siegfried Holding AG - Key offerings
- Siegfried Holding AG - Segment focus
- SWOT
15.16 Syngene International Ltd.
- Syngene International Ltd. - Overview
- Syngene International Ltd. - Product / Service
- Syngene International Ltd. - Key offerings
- SWOT
15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
15.18 WuXi AppTec Co. Ltd.
- WuXi AppTec Co. Ltd. - Overview
- WuXi AppTec Co. Ltd. - Business segments
- WuXi AppTec Co. Ltd. - Key offerings
- WuXi AppTec Co. Ltd. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations